Oct 23, 2024 08:01AM
Oct 23, 2024 08:00AM
Aug 1, 2024 04:51PM
Aug 1, 2024 04:05PM
Jul 23, 2024 04:05PM
May 15, 2024 04:13AM
May 14, 2024 04:15PM Lumos Pharma (LUMO) Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
May 14, 2024 04:15PM
May 9, 2024 02:51PM
Mar 7, 2024 04:36PM
Mar 7, 2024 04:01PM
Feb 26, 2024 09:00AM
Nov 7, 2023 05:32PM
Nov 7, 2023 04:35PM Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates
Aug 9, 2023 04:38PM
Aug 9, 2023 04:01PM
Jul 26, 2023 09:00AM
May 3, 2023 04:05PM
Apr 19, 2023 09:00AM
Apr 19, 2023 09:00AM
Mar 1, 2023 04:32PM Lumos Pharma, Inc. (LUMO) Misses Q4 EPS by 278c
Mar 1, 2023 04:05PM
Mar 1, 2023 04:05PM
Feb 15, 2023 04:05PM
Feb 15, 2023 04:05PM
Nov 14, 2022 06:10AM
Nov 14, 2022 06:10AM
Aug 9, 2022 04:01PM Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
Aug 9, 2022 04:01PM
Jul 27, 2022 04:05PM
Jul 27, 2022 04:05PM
May 10, 2022 05:39PM
May 10, 2022 04:01PM
May 10, 2022 04:01PM
Apr 26, 2022 09:00AM Lumos Pharma to Report First Quarter 2022 Financial Results and Host Conference Call on May 10, 2022
Apr 26, 2022 09:00AM
Mar 10, 2022 04:03PM
Mar 10, 2022 04:01PM
Mar 10, 2022 04:01PM
Feb 23, 2022 09:00AM
Feb 23, 2022 09:00AM
Nov 3, 2021 04:01PM Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates
Nov 3, 2021 04:01PM
Oct 21, 2021 04:05PM
Oct 21, 2021 04:05PM
Aug 5, 2021 08:41AM
Aug 5, 2021 08:00AM
Aug 5, 2021 08:00AM
Jul 22, 2021 08:00AM Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021
Jul 22, 2021 08:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All